EC Number | Inhibitors | Comment | Organism | Structure |
---|---|---|---|---|
3.1.4.12 | imipramine | - |
Mus musculus | |
3.1.4.12 | imipramine | - |
Sus scrofa |
EC Number | Organism | UniProt | Comment | Textmining |
---|---|---|---|---|
3.1.4.12 | Mus musculus | - |
- |
- |
3.1.4.12 | Sus scrofa | - |
- |
- |
EC Number | Source Tissue | Comment | Organism | Textmining |
---|---|---|---|---|
3.1.4.12 | lung | - |
Mus musculus | - |
3.1.4.12 | lung | - |
Sus scrofa | - |
EC Number | Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|---|
3.1.4.12 | sphingomyelin + H2O | - |
Mus musculus | N-acylsphingosine + choline phosphate | - |
? | |
3.1.4.12 | sphingomyelin + H2O | - |
Sus scrofa | N-acylsphingosine + choline phosphate | - |
? |
EC Number | Synonyms | Comment | Organism |
---|---|---|---|
3.1.4.12 | A-SMase | - |
Mus musculus |
3.1.4.12 | A-SMase | - |
Sus scrofa |
3.1.4.12 | acid sphingomyelinase | - |
Mus musculus |
3.1.4.12 | acid sphingomyelinase | - |
Sus scrofa |
EC Number | General Information | Comment | Organism |
---|---|---|---|
3.1.4.12 | malfunction | acid SMase-deficient mice show reduced pulmonary ceramide levels and attenuated leukocyte influx into the alveolar space | Mus musculus |